ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag vaccine disease medicine immunology vision

Histology of mouse lungs using purple and green staining on a white background. Left: a healthy lung. Right: a fibrotic lung.<br><br>
Immunotherapy Treats Fibrosis in Mice
Alejandra Manjarrez, PhD | Sep 15, 2022 | 4 min read
Researchers report that vaccination against proteins found on profibrotic cells reduced liver and lung fibrosis in laboratory rodents.
2020 in Scientists’ Own Words
Abby Olena, PhD | Dec 23, 2020 | 5 min read
The world was rocked by the COVID-19 pandemic this year, but researchers rose to all manner of challenges.
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018 | 2 min read
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
an illustration of a woman holding her head
Could COVID-19 Trigger Chronic Disease in Some People?
Katarina Zimmer | Jul 17, 2020 | 8 min read
A handful of viruses have been associated with long-term, debilitating symptoms in a subset of those who become infected. Early signs hint that SARS-CoV-2 may do the same.
No Mo’ Slow Flow
Jeffrey M. Perkel | Jan 1, 2012 | 7 min read
Tools and tricks for high-throughput flow cytometry
Vaccine Program Could Spawn Opportunities For Researchers
Ron Kaufman | Aug 22, 1993 | 4 min read
A report released last month by the Institute of Medicine (IOM) proposes the creation of a National Vaccine Authority (NVA) to oversee the entire process of vaccine research and development in the United States. The authority will also act as a liaison between the federal government and private industry for vaccine production. The report discusses, among other topics, the role of applied research in the development of new or improved vaccines against such diseases as tetanus and cholera both
How Some Vaccines Protect Against More than Their Targets
Shawna Williams | Nov 1, 2020 | 10+ min read
As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.
For the Greater Good: A Profile of Eva Harris
Diana Kwon | Jul 13, 2020 | 10 min read
Through groundbreaking studies on dengue and efforts to build scientific infrastructure in Latin America, the University of California, Berkeley, professor has bridged research with its benefits to society.
Long-Lived Immune Memories
Anna Azvolinsky | Dec 9, 2015 | 3 min read
Two types of memory T cells can preserve immunological memories for more than a decade, a study shows. 
Vaccines: Victims of Their Own Success?
Ricki Lewis | Jul 18, 2004 | 10+ min read
Perhaps in no area is the divide between the developed and developing worlds as striking as it is for vaccines: While healthcare consumers in economically advantaged nations worry about risk, in developing nations compelling need forces a focus on potential benefit. "People in the United States want a quick solution, not prevention, so they prefer drugs to vaccines. Elsewhere, people are afraid of drugs and side effects, and prefer vaccines," says Shan Lu, a primary-care physician who has worked

Run a Search

ADVERTISEMENT